Barbara Messore

820 total citations
18 papers, 401 citations indexed

About

Barbara Messore is a scholar working on Pulmonary and Respiratory Medicine, Speech and Hearing and Infectious Diseases. According to data from OpenAlex, Barbara Messore has authored 18 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 3 papers in Speech and Hearing and 1 paper in Infectious Diseases. Recurrent topics in Barbara Messore's work include Cystic Fibrosis Research Advances (18 papers), Tracheal and airway disorders (8 papers) and Neonatal Respiratory Health Research (6 papers). Barbara Messore is often cited by papers focused on Cystic Fibrosis Research Advances (18 papers), Tracheal and airway disorders (8 papers) and Neonatal Respiratory Health Research (6 papers). Barbara Messore collaborates with scholars based in Italy, France and Belgium. Barbara Messore's co-authors include Donatello Salvatore, V. Lucidi, Roberto Buzzetti, Valeria Raia, Ermanno Baldo, G. Mastella, Anna Silvia Neri, Maria Lucia Furnari, Michela Francalanci and Giuseppe Cimino and has published in prestigious journals such as PLoS ONE, Materials Science and Engineering C and Cells.

In The Last Decade

Barbara Messore

16 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Messore Italy 10 337 60 43 40 27 18 401
Rosaria Casciaro Italy 12 280 0.8× 52 0.9× 53 1.2× 40 1.0× 35 1.3× 29 354
Marcia Craib United States 4 388 1.2× 67 1.1× 43 1.0× 18 0.5× 45 1.7× 6 422
Abaigeal Jackson Ireland 8 276 0.8× 38 0.6× 58 1.3× 20 0.5× 24 0.9× 16 361
Paul H. Sammut United States 10 228 0.7× 45 0.8× 23 0.5× 83 2.1× 37 1.4× 17 318
Isabelle de Monestrol Sweden 8 220 0.7× 40 0.7× 23 0.5× 33 0.8× 19 0.7× 17 263
Margaret Kloster United States 15 604 1.8× 125 2.1× 80 1.9× 42 1.1× 79 2.9× 26 685
Jonathan D. Cogen United States 11 366 1.1× 130 2.2× 54 1.3× 16 0.4× 25 0.9× 48 450
Laura Claut Italy 13 211 0.6× 145 2.4× 28 0.7× 50 1.3× 32 1.2× 21 420
W.G. Flight United Kingdom 12 290 0.9× 175 2.9× 64 1.5× 32 0.8× 26 1.0× 35 428
Alastair Reid United Kingdom 10 179 0.5× 20 0.3× 58 1.3× 28 0.7× 41 1.5× 15 271

Countries citing papers authored by Barbara Messore

Since Specialization
Citations

This map shows the geographic impact of Barbara Messore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Messore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Messore more than expected).

Fields of papers citing papers by Barbara Messore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Messore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Messore. The network helps show where Barbara Messore may publish in the future.

Co-authorship network of co-authors of Barbara Messore

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Messore. A scholar is included among the top collaborators of Barbara Messore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Messore. Barbara Messore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Salvatore, Donatello, Paola Iacotucci, Angela Pepe, et al.. (2025). Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes. Respiratory Medicine. 245. 108221–108221. 1 indexed citations
2.
Tiddens, Harm A.W.M., Michaël Fayon, Pierluigi Ciet, et al.. (2023). 146 Standardizing European imaging practice: European Cystic Fibrosis Society—Clinical Trial Network Imaging Special Interest Groups. Journal of Cystic Fibrosis. 22. S77–S77. 1 indexed citations
3.
Gramegna, Andrea, Stefano Aliberti, Maria Adelaide Calderazzo, et al.. (2023). The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus. Respiratory Medicine. 220. 107455–107455. 4 indexed citations
4.
Gramegna, Andrea, Stefano Aliberti, Adelina Amorim, et al.. (2023). Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis. Journal of Cystic Fibrosis. 23(2). 306–313.
5.
Saluzzo, Francesca, Barbara Messore, Nicola Ivan Lorè, et al.. (2022). CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis. Cells. 11(7). 1243–1243. 29 indexed citations
6.
Taccetti, Giovanni, Michela Francalanci, Giovanna Pizzamiglio, et al.. (2021). Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives. Antibiotics. 10(3). 338–338. 64 indexed citations
7.
Colombo, Carla, Gianfranco Alicandro, Valeria Daccò, et al.. (2021). SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020. PLoS ONE. 16(5). e0251527–e0251527. 15 indexed citations
8.
Salvatore, Donatello, Vito Terlizzi, Michela Francalanci, et al.. (2020). Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. Respiratory Medicine. 171. 106073–106073. 24 indexed citations
9.
Salvatore, Donatello, C. Braggion, Maria Adelaide Calderazzo, et al.. (2019). P254 Ivacaftor treatment in patients with severe lung disease carrying CFTR mutations with residual function. Journal of Cystic Fibrosis. 18. S128–S129. 1 indexed citations
10.
Blasi, Francesco, Vincenzo Carnovale, Giuseppe Cimino, et al.. (2018). Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study. Respiratory Medicine. 138. 88–94. 13 indexed citations
11.
Cristallini, Caterina, Niccoletta Barbani, Sara Filippi, et al.. (2018). Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier. Materials Science and Engineering C. 95. 19–28. 12 indexed citations
12.
Salvatore, Donatello, et al.. (2018). IPD2.05 Effects of ivacaftor in patients with cystic fibrosis and severe lung disease carrying CFTR mutations with residual function. Journal of Cystic Fibrosis. 17. S54–S55. 1 indexed citations
13.
Clivati, Elisa, et al.. (2018). Real life experience of lumacaftor/ivacafotor in adult Phe508del homozygous cystic fibrosis patients.. PA1322–PA1322. 1 indexed citations
14.
15.
Salvatore, Donatello, Roberto Buzzetti, Ermanno Baldo, et al.. (2012). An overview of international literature from cystic fibrosis registries. Part 4: Update 2011. Journal of Cystic Fibrosis. 11(6). 480–493. 35 indexed citations
16.
17.
Salvatore, Donatello, Roberto Buzzetti, Ermanno Baldo, et al.. (2009). An overview of international literature from cystic fibrosis registries. Journal of Cystic Fibrosis. 9(2). 75–83. 73 indexed citations
18.
Buzzetti, Roberto, Donatello Salvatore, Ermanno Baldo, et al.. (2009). An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. Journal of Cystic Fibrosis. 8(4). 229–237. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosaria Casciaro Breakdown of academic impact, for papers by Marcia Craib Breakdown of academic impact, for papers by Abaigeal Jackson Breakdown of academic impact, for papers by Paul H. Sammut Breakdown of academic impact, for papers by Isabelle de Monestrol Breakdown of academic impact, for papers by Margaret Kloster Breakdown of academic impact, for papers by Jonathan D. Cogen Breakdown of academic impact, for papers by Laura Claut Breakdown of academic impact, for papers by W.G. Flight Breakdown of academic impact, for papers by Alastair Reid
Rankless by CCL
2026